TO SAVE ONE IS TO SAVE ALL
Helping medicines reach the patients who need them — safely, compliantly and in a commercially viable way.
Senior, founder-led consultancy across regulatory affairs, medical information & final signatory, pharmacovigilance and market access — for pharmaceutical companies, consultancies, CROs and manufacturers across the UK, EU & Gulf.
Our Services
Pharmaceutical Strategy & Portfolio Advisory
Board-level strategic direction for products and portfolios — positioning, licensing routes, indication and lifecycle planning, and market-entry readiness. We turn complex options into one clear, commercially viable plan.
Medical Affairs & Scientific Advisory
Senior medical affairs and scientific advisory — evidence review and literature appraisal, medical strategy, scientific positioning, medical writing and HCP-facing materials — aligning your clinical credibility with regulatory, medical and commercial objectives.
Regulatory Affairs & Lifecycle Management
End-to-end regulatory affairs across UK, EU, Gulf and international pathways — submissions, variations, renewals, SmPC/PIL and product information — keeping your portfolio compliant, current and commercially relevant. Post-Brexit UK licensing a speciality.
Product Development, CMC & Technical Dossier Support
Technical and CMC advisory from formulation to filing — quality documentation, manufacturing considerations, stability, Module 3 readiness and dossier planning — connecting product-design decisions to regulatory and launch requirements.
Medical Information & Scientific Communications
A compliant medical information service — accurate, balanced responses to HCP, patient and carer enquiries, standard response documents, enquiry triage and PV interfacing — protecting both your brand and your patients.
Pharmacovigilance, RMPs & Safety Governance
Pharmacovigilance built to inspection-ready standard — PSMF, RMPs, ICSR and safety-escalation pathways, SOPs, training, CAPA and audit readiness — aligned to GVP and MHRA expectations.
Compliance, ABPI/PMCPA & Healthcare Governance
ABPI/PMCPA compliance and Final Medical Signatory support — MLR review, certification and examination of promotional and non-promotional materials, and SOP frameworks — keeping your communications compliant and defensible.
Market Access, Category Switch & Commercial Strategy
UK market access and commercial strategy — pricing and reimbursement, NHS listing, dm+d visibility, Drug Tariff, formulary access and category switch — engineered for launch success and sustainable uptake.
Strategic Partnerships, Ventures & International Expansion
Bi-directional UK ↔ Gulf expansion and partnership advisory — market entry, local-partner strategy and investor-facing support across the UK, Saudi Arabia and the wider Gulf — from concept to commercial growth.
Why Partner With Saviours Pharma Consultancy?
Senior Pharmaceutical Expertise
Over 20 years’ experience across regulatory affairs, medical affairs, pharmacovigilance, compliance, market access and commercial strategy.
End-to-End Lifecycle Insight
Support from concept and product development through licensing, governance, market access, launch and lifecycle optimisation.
UK, Saudi & Gulf Market Focus
Strategic understanding of UK, Saudi Arabia and Gulf healthcare opportunities, including market entry, partnerships, regulatory pathways, healthcare access and commercial development.
Flexible Delivery Model
Available as a strategic adviser, project lead, associate consultant, subcontract partner or embedded member of a wider delivery team.